Literature DB >> 6287653

Susceptibility of dermatiaceous fungi to amphotericin B, miconazole, ketoconazole, flucytosine and rifampin alone and in combination.

M L Corrado, M Kramer, M Cummings, R H Eng.   

Abstract

The dematiaceous fungi comprise a group of organisms that are deeply pigmented and found in soil or on decaying organic material, such as wood. The majority of infections with these fungi presumably results from traumatic inoculation. Although various forms of infection have been appreciated for some time, none of the presently available antifungal drugs have been shown to have predictable activity against these organisms. We report on the activity in vitro of various antifungal agents alone and in combination against various dematiaceous fungi.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6287653     DOI: 10.1080/00362178285380181

Source DB:  PubMed          Journal:  Sabouraudia        ISSN: 0036-2174


  10 in total

1.  Cutaneous phaeohyphomycosis caused by Phialophora richardsiae and the effect of topical clotrimazole in its treatment.

Authors:  S M Singh; A Agrawal; J Naidu; G S de Hoog; M J Figueras
Journal:  Antonie Van Leeuwenhoek       Date:  1992-01       Impact factor: 2.271

2.  Feline phaeohyphomycosis: treatment with ketaconazole and 5-fluorocytosine.

Authors:  B P Pukay; W M Dion
Journal:  Can Vet J       Date:  1984-03       Impact factor: 1.008

3.  Loss of melanin in Wangiella dermatitidis does not result in greater susceptibility to antifungal agents.

Authors:  A Polak; D M Dixon
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

Review 4.  Overview of medically important antifungal azole derivatives.

Authors:  R A Fromtling
Journal:  Clin Microbiol Rev       Date:  1988-04       Impact factor: 26.132

Review 5.  Compounds active against cell walls of medically important fungi.

Authors:  R F Hector
Journal:  Clin Microbiol Rev       Date:  1993-01       Impact factor: 26.132

6.  In vitro activity of seven azole compounds against some clinical isolates of non-dermatophytic filamentous fungi and some dermatophytes.

Authors:  C A Oyeka; H C Gugnani
Journal:  Mycopathologia       Date:  1990-06       Impact factor: 2.574

Review 7.  Melanized fungi in human disease.

Authors:  Sanjay G Revankar; Deanna A Sutton
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

8.  Nikkomycin Z supersensitivity of an echinocandin-resistant mutant of Saccharomyces cerevisiae.

Authors:  M el-Sherbeini; J A Clemas
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

9.  In vitro sensitivity of environmental isolates of pathogenic dematiaceous fungi to azole compounds and a phenylpropyl-morpholine derivative.

Authors:  C N Okeke; H C Gugnani
Journal:  Mycopathologia       Date:  1987-09       Impact factor: 2.574

10.  Positive interaction of nikkomycins and azoles against Candida albicans in vitro and in vivo.

Authors:  R F Hector; K Schaller
Journal:  Antimicrob Agents Chemother       Date:  1992-06       Impact factor: 5.191

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.